Navigation Links
Food and Beverage Giant Joins Kannapolis Research Center
Date:10/20/2008

  • Promoting Healthy Kids Lifestyles. PepsiCo understands the value the in helping kids lead healthier lives by offering healthy product choices in schools, by developing healthy products that appeal to kids and by promoting programs that encourage kids to lead active lives.

  • "At PepsiCo, we recognize the need to stay at the forefront of nutrition knowledge. Increasingly, future innovation will be driven by leading-edge science," said Mehmood Khan, PepsiCo's Chief Scientific Officer. "Through our partnership with the North Carolina Research Campus, we're confident that the collaborative research of some of the world's leading nutrition academic researchers and PepsiCo scientists will result in further advancement in nutrition and health and ultimately the best products for consumers." Dr. Khan, an endocrinologist and veteran of pharmaceutical industry, guides the PepsiCo's long-term research strategy and agenda for business opportunities.

    The prospect of having the top industry and academic scientists on one Campus is compelling on its own. But when coupled with top research facilities and scientific instrumentation, this strategy will truly enable the great new discoveries to get to the consumers much quicker, says Clyde Higgs, Vice President, Business Development for the Research Campus.

    About the NC Research Campus
    Planned as a public-private partnership on 350-acres of real estate in Kannapolis (Charlotte), the North Carolina Research Campus combines the research power of nine world-renowned universities and colleges in North Carolina. It is the vision of David H. Murdock, University of North Carolina system, Duke University, and the N.C. Community College System. In addition to PepsiCo, other companies that will have a presence at the Campus include LabCorp, PPD Inc, Dole Food Inc, Redhat, Carolinas Medical Center, Anatomics, and Sensory Spectrum. Dole Food Inc owner David Murdock has committed over a
    '/>"/>

    Source: PRWeb
    Copyright©2008 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Yale scientists make 2 giant steps in advancement of quantum computing
    2. Mark Sutherland Joins GenVault as Senior Vice President, Business Development
    3. Chief Technology Officer Joins ACAMP
    4. Charles C. Harwood, Jr., Joins Cellectar, Inc.s Board of Directors
    5. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
    6. David Hsia, Ph.D. Joins Kinex Pharmaceuticals Board of Directors
    7. Dr. Paul Korner Joins Ferring Pharmaceuticals as Vice President, Medical Affairs
    8. The National Cancer Institute Joins the Global Community of Scientists Now Using BIOMARKERcenter From Thomson Reuters
    9. GM Exec Joins Bio-Reaction Industries Board of Directors
    10. Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development
    11. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... , ... July 30, 2015 , ... The 2015 Market ... study on the current state of the global Propanol market with a focus on ... BASF, Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG ...
    (Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
    (Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
    (Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
    Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7
    ... COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: ... its fourth quarter and fiscal year 2008 on December 11, 2008, ... at 4:45 p.m. ET Martek will conduct a conference call to ... to the call live via webcast by visiting Martek,s web site ...
    ... Early to Mid-2009 , , ... the proprietary products division of Par Pharmaceutical Companies, Inc. ... development partner, MonoSol Rx, reported the successful completion of ... of ondansetron. The ondansetron thin film product is being ...
    ... (BCI), a,biopharmaceutical company utilizing its platform technology to ... new neurons for the treatment of,central nervous system ... Thompson to its board of directors. Thompson is ... tenure at Eli Lilly and Co. where he,focused ...
    Cached Biology Technology:Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4BrainCells Inc. Appoints David E. Thompson to Its Board of Directors 2BrainCells Inc. Appoints David E. Thompson to Its Board of Directors 3
    (Date:7/9/2015)... 9, 2015  Unchained Labs just can,t get ... of Avid Nano. Avid Nano designs, develops and ... Also today, Unchained Labs UNcaged ... to use protein sizing system. The pUNk is ... hydrodynamic size, size distribution, aggregation population and molecular ...
    (Date:7/8/2015)... -- Summary Pancreatic cancer is the 12th most ... a mortality rate of 10.9 deaths per 100,000 people ... has highlighted a significant need for new and improved ... the current market. A highly active pancreatic cancer ... types and mechanisms of action, which provides a striking ...
    (Date:7/8/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a ... launch of a study that aims to determine ... technology for predicting response to treatment in advanced ... the novel immunotherapy agents Yervoy® (ipilumumab), a CTLA-4 ... 50-patient study will be led by researchers at ...
    Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
    ... COLUMBUS, Ohio Very few athletic trainers associated with ... were following best practice standards for managing asthma among ... athletes with asthma, the dangers of the condition can ... severe to be incapacitating, or deadly. The lead report ...
    ... and inanimate phenomena may have more in common than previously ... University engineer Adrian Bejan and Penn State biologist James Marden. ... theory that flow systems from animal locomotion to the ... and minimize imperfections. Flows evolve to reduce friction or other ...
    ... Conan Doyle,s account of an isolated community of dinosaurs that ... no less appeal now than it did when it was ... recreate the lost world of dinosaurs, but today the fiction ... suggests that dinosaur bones from the Ojo Alamo Sandstone in ...
    Cached Biology News:Athletes with asthma need more help from their team trainers 2Unifying the animate and the inanimate designs of nature 2Evidence of the 'Lost World' -- did dinosaurs survive the end Cretaceous extinctions? 2
    ... enclosures are designed for ... other process gas to ... HEPA filtration, heating/cooling, humidification, ... also available, along with ...
    ... the professional, student, or faculty researcher, the new ... your research and improve the quality of your ... the edge that researchers using LI-COR DNA analysis ... The 4300 System is a third generation instrument ...
    This modular benchtop fume hood ventilates and purifies chemical fumes, allowing safe indoor release of exhaust. Bonded charcoal filters remove most organic contaminants. Options include final HEPA f...
    ... determined by Biuret. Physical form: ... 4 ) 2 SO 4 ... Affinity purified • Physical Form: ... MgCl 2 1 ZnCl ...
    Biology Products: